• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Greece stocks lower at close of trade; Athens General Composite down 0.81%

by November 18, 2024
written by November 18, 2024

Investing.com – Greece stocks were lower after the close on Monday, as losses in the Telecoms, Household and Basic Resources sectors led shares lower.

At the close in Athens, the Athens General Composite declined 0.81%.

The best performers of the session on the Athens General Composite were Eurobank Ergasias SA (AT:EURBr), which rose 2.03% or 0.04 points to trade at 2.01 at the close. Meanwhile, Elinoil Hellenic Petroleum Company SA (AT:ELIr) added 1.99% or 0.04 points to end at 2.05 and Athens Water (AT:EYDr) was up 1.40% or 0.08 points to 5.78 in late trade.

The worst performers of the session were Viohalco SA (AT:VIOH), which fell 4.14% or 0.22 points to trade at 5.10 at the close. Fourlis Hld (AT:FRLr) declined 3.76% or 0.14 points to end at 3.58 and Intralot (AT:INLr) was down 3.04% or 0.03 points to 0.89.

Falling stocks outnumbered advancing ones on the Athens Stock Exchange by 91 to 31 and 14 ended unchanged.

Shares in Viohalco SA (AT:VIOH) fell to 52-week lows; losing 4.14% or 0.22 to 5.10. Shares in Intralot (AT:INLr) fell to 52-week lows; down 3.04% or 0.03 to 0.89.

Gold Futures for December delivery was up 1.71% or 43.85 to $2,613.95 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 2.84% or 1.90 to hit $68.82 a barrel, while the January Brent oil contract rose 2.77% or 1.97 to trade at $73.01 a barrel.

EUR/USD was unchanged 0.28% to 1.06, while EUR/GBP unchanged 0.29% to 0.84.

The US Dollar Index Futures was down 0.18% at 106.43.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
next post
India’s competition regulator imposes $25.4 million fine on Meta for WhatsApp’s 2021 privacy policy

You may also like

Adani, Ambani news units sue OpenAI over copyright,...

March 13, 2026

China’s DeepSeek sets off AI market rout

March 13, 2026

BASF results down on impairments, restructuring

March 13, 2026

Nasdaq futures tumble as China’s AI push rattles...

March 13, 2026

European chipmakers slump as traders gauge DeepSeek AI...

March 13, 2026

China Vanke’s CEO, chairman resign amid growing liquidity...

March 13, 2026

Fuji Media, rocked by sexual misconduct allegations, says...

March 13, 2026

Italy’s MPS shares fall ahead of Mediobanca board...

March 13, 2026

UMG shares rally after new multi-year pact with...

March 13, 2026

British Land stock drops following stake sale

March 13, 2026
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Trump administration alleges Nike discriminated against white workers

      March 13, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      March 13, 2026
    • Retail operator of outdoor sportswear pioneer Eddie Bauer files for bankruptcy

      March 13, 2026
    • Cardi B’s cameo in Bad Bunny’s Super Bowl halftime show leads to dispute on prediction markets

      March 13, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (690)
    • Stock (6,426)

    Latest News

    • Trump administration alleges Nike discriminated against white workers
    • Landmark trial accusing social media companies of addicting children to their platforms begins

    Popular News

    • Canada considers retaliatory tariffs on orange juice, other US goods, paper says
    • Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy